Search Results - "Nakou, Eleni S."

Discrete aortic dissection: the Achilles' heel of emergency cardiovascular medicine by Nakou, Eleni S, Papasaikas, Dimitrios, Deshpande, Ranjit, Papachristidis, Alexandros

Get full text

A 12-Week, Prospective, Open-Label Analysis of the Effect of Rosuvastatin on Triglyceride-Rich Lipoprotein Metabolism in Patients with Primary Dyslipidemia by Kostapanos, Michael S., MD, Milionis, Haralampos J., MD, Filippatos, Theodosios D., MD, Nakou, Eleni S., MD, Bairaktari, Eleni T., PhD, Tselepis, Alexandros D., MD, PhD, Elisaf, Moses S., MD, FRSH

“…Abstract Background: Although the effect of statins on lowering low-density lipoprotein cholesterol (LDL-C) has been extensively studied, their…”
Get full text

Orlistat-Associated Adverse Effects and Drug Interactions: A Critical Review by Filippatos, Theodosios D., Derdemezis, Christos S., Gazi, Irene F., Nakou, Eleni S., Mikhailidis, Dimitri P., Elisaf, Moses S.

“…Orlistat, an anti-obesity drug, is a potent and specific inhibitor of intestinal lipases. In light of the recent US FDA approval of the over-the-counter sale…”
Get full text

Isolated papillary muscle rupture with nonobstructive coronary artery disease, minimal myocardial infarction, and normal wall motion by Nakou, Eleni S., Theodoropoulos, Konstantinos C., Shaikh, Hizbullah, Amin‐Youssef, George, Monaghan, Mark J., Papachristidis, Alexandros

“…Papillary muscle (PM) rupture can usually complicate inferior or posterior myocardial infarctions, but selective PM infarction is extremely rare, and the exact…”
Get full text

Upgrading or downgrading a cardiac resynchronization therapy device (CRT) device? Gaps and dilemmas in current clinical practice by Simantirakis, Emmanuel N, Nakou, Eleni S, Vardas, Panos E

Get full text

Troponin‐I levels as a potential prognostic biomarker of sacubitril/valsartan treatment response in heart failure with reduced ejection fraction: Who will benefit most? by Nakou, Eleni S., Marketou, Maria E., Chlouverakis, Gregory I., Patrianakos, Alexandros P., Vardas, Panos E., Parthenakis, Fragiskos I.

“…Background Despite robust data on the benefits of sacubitril/valsartan (LCZ696) in patients with chronic heart failure with reduced ejection fraction (HFrEF),…”
Get full text

The clinical relevance of drug–drug interaction between co-trimoxazole and sacubitril/valsartan treatment in a heart failure patient: a case report and overview of mechanisms and management in clinical practice by Nakou, Eleni S., Marketou, Maria E., Vardas, Panos E., Parthenakis, Fragiskos I.

Get full text

Cardiac resynchronization therapy (CRT) device replacement considerations: upgrade or downgrade? A complex decision in the current clinical setting by Nakou, Eleni S, Simantirakis, Emmanuel N, Kallergis, Eleftherios M, Nakos, Konstantinos S, Vardas, Panos E

“…There are limited data about the management of patients presenting for elective generator replacements in the setting of previously implanted cardiac…”
Get full text

Short-term effects of angiotensin receptor-neprilysin inhibitors on diastolic strain and tissue doppler parameters in heart failure patients with reduced ejection fraction: A pilot trial by Nakou, Eleni S., Marketou, Maria E., Patrianakos, Alexandros, Protonotarios, Alexandros, Vardas, Panos E., Parthenakis, Fragiskos I.

“…Although sacubitril/valsartan has recently shown its long-term benefits on morbidity and mortality in symptomatic patients with chronic heart failure with…”
Get full text

New therapeutic options in heart failure. What's on the horizon? An overview by Nakou, Eleni S, Vardas, Panagiotis E

“…Abstract Heart failure is a complex clinical syndrome responsible for high morbidity and mortality in the world. Despite advances in the management of heart…”
Get full text

Chronotropic incompetence presenting as sudden sinus slowing during exercise stress test: the pathophysiological mechanisms by Kallergis, Eleftherios M., Nakou, Eleni S., Simantirakis, Emmanuel N., Vardas, Panos E.

Get full text

Alterations in the expression of genes related to contractile function and hypertrophy of the left ventricle in chronically paced patients from the right ventricular apex by Arkolaki, Eva G, Simantirakis, Emmanuel N, Kontaraki, Joanna E, Chrysostomakis, Stavros I, Patrianakos, Alexandros P, Chlouverakis, Gregory I, Nakou, Eleni S, Vardas, Panos E

“…Long-term right ventricular apical (RVA) pacing may lead to left ventricular (LV) remodelling and heart failure. This study assessed changes in the expression…”
Get full text

Are diabetic patients at increased risk of arrhythmias? by Nakou, Eleni S, Mavrakis, Hercules, Vardas, Panos E

Get full text

The role of C-reactive protein in atherosclerotic cardiovascular disease: an overview by Nakou, Eleni S, Liberopoulos, Evangelos N, Milionis, Haralampos J, Elisaf, Moses S

“…C-reactive protein (CRP) is an acute-phase protein, which has been used in clinical practice as a non specific marker of inflammation. Many studies have shown…”
Get more information

Efficacy and safety of ezetimibe plus orlistat or rimonabant in statin-intolerant nondiabetic overweight/obese patients with dyslipidemia by Florentin, Matilda, Kostapanos, Michael S, Nakou, Eleni S, Elisaf, Moses, Liberopoulos, Evangelos N

“…To compare the effects of ezetimibe plus orlistat or rimonabant on anthropometric and lipid parameters in nondiabetic statin-intolerant overweight/obese…”
Get more information

Chronotropic incompetence presenting as sudden sinus slowing during exercise stress test: the pathophysiological mechanisms by Kallergis, Eleftherios M, Nakou, Eleni S, Simantirakis, Emmanuel N, Vardas, Panos E

Get full text